April 2023
·
4 Reads
Pancreatic cancer remains one of the most lethal malignancies in the world. Most patients diagnosed with pancreatic cancer present at an advanced stage of the disease. Therefore, early diagnosis and accurate staging are essential in the management of these patients. Cross-sectional imaging techniques and interventional endoscopies such as endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) play an important role in the initial evaluation, staging, and treatment of pancreatic lesions. Progressive biliary obstruction is often expected in pancreatic cancer, which could result in cholangitis, cholestasis, pruritus, liver failure, and premature mortality. Endoscopy-guided biliary decompression (ERCP and EUS) in resectable and unresectable tumors has gained more ground by replacing percutaneous drainage and surgery as the first approach. The main advantage of EUS over ERCP sampling is the possibility of obtaining a tissue diagnosis by performing fine needle aspiration biopsy (EUS-FNA), however, ERCP-guided biliary sampling could be performed first if a concurrent biliary decompression is required. Contrast-enhanced EUS and elastography are ancillary techniques that could be useful in clinical practice. Moreover, there are emerging EUS-guided therapeutic techniques that play an essential role in the management of pancreatic cancer.KeywordsPancreatic cancerEndoscopic ultrasoundEndoscopic ultrasound-guide fine needle aspirationEndoscopic retrograde cholangiopancreatographyBiliary drainage